Cardiff Oncology Files Q1 2025 10-Q
Ticker: CRDF · Form: 10-Q · Filed: May 8, 2025 · CIK: 1213037
| Field | Detail |
|---|---|
| Company | Cardiff Oncology, Inc. (CRDF) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Cardiff Oncology's Q1 2025 10-Q is in. Check salaries & professional fees.
AI Summary
Cardiff Oncology, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial items include salaries and staff costs, and outside services and professional fees for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial snapshot of Cardiff Oncology, including operational expenses for the first quarter of 2025, which is crucial for understanding the company's financial health and strategic direction.
Risk Assessment
Risk Level: medium — As a biotechnology company, Cardiff Oncology faces inherent risks related to drug development, clinical trials, and regulatory approvals, which can significantly impact its financial performance.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial data)
- 2024-01-01 to 2024-03-31 — Salaries and Staff Costs Period (Specific period for salary expenses)
- 2025-01-01 to 2025-03-31 — Outside Services and Professional Fees Period (Specific period for external service expenses)
Key Players & Entities
- Cardiff Oncology, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- Trovagene, Inc. (company) — Former company name
- XENOMICS INC (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What were the 'Salaries and Staff Costs' for Cardiff Oncology in the first quarter of 2024?
The filing indicates 'Salaries and Staff Costs' for the period of January 1, 2024, to March 31, 2024.
What is the company's fiscal year end?
Cardiff Oncology's fiscal year ends on December 31.
What are some of the former names of Cardiff Oncology?
Former names include Trovagene, Inc. and XENOMICS INC.
When was the company's name last changed to Cardiff Oncology, Inc.?
The filing indicates a name change date of March 4, 2013, from Trovagene, Inc.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Cardiff Oncology, Inc. (CRDF).